|
HS Code |
178514 |
| Product Name | Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid |
| Cas Number | 144398-37-0 |
| Molecular Formula | C15H20BrNO4 |
| Molecular Weight | 358.23 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Chemical Class | Protected amino acid derivative |
| Protection Group | Boc (tert-butoxycarbonyl) |
| Chirality | R-enantiomer |
| Solubility | Soluble in organic solvents like DMSO and DMF |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Synonyms | tert-Butyl (R)-3-amino-4-(2-bromophenyl)butanoate |
As an accredited Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry keeps changing the way research works, especially for those who spend long days at the bench designing new pathways. Nowhere does this ring more true than in the field of amino acid derivatives, where every tweak—no matter how minor—affects downstream work. Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid stands out for more than just its name. Its unique substitution pattern, with a bromine placed at the second position of the phenyl ring, adds a layer of versatility I’ve relied on when exploring substrate flexibility in peptide chain synthesis.
Chirality isn’t just a buzzword—handedness shapes outcomes in both medicine development and materials. Time and again, the (R)-enantiomer of amino acids delivers different biological activities compared to its mirror image. This version of Boc-3-Amino-4-(2-Bromophenyl)-Butyric Acid uses (R)-configurational purity, which directly matters if the application touches pharmaceuticals or advanced peptide library screens. Synthetic approaches often run into trouble without this attention to stereochemistry. Impurities stemming from racemates introduce wasted effort and muddy results. Here, strict adherence to optical purity streamlines the route, so you end up with cleaner data and more satisfying yields.
Researchers in medicinal chemistry know the frustration of unwanted side reactions. The t-butoxycarbonyl (Boc) group serves as a reliable guard, shielding the alpha-amino function during tough synthetic routes. In daily lab practice, I’ve found Boc-protected compounds tolerate a lot, especially during steps demanding strong reagents or broad pH ranges. Removing the Boc group remains a straightforward task, needing only mild acidic conditions, and rarely interferes with sensitive moieties found elsewhere in the molecule. Conventional wisdom holds up—Boc protection gets more projects across the finish line without upping the risk of decomposition or retracing steps.
Anyone who's run Suzuki or Sonogashira couplings knows the advantage of a bromine atom at a strategic spot on an aromatic ring. The 2-bromo substituent on the phenyl portion of Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid leaves the door open for all sorts of functionalizations down the line. This specific positioning means, whether you plan creative expansions by palladium-catalyzed cross-coupling, or want to add new groups via classic aromatic chemistry, the molecule plays along. That kind of flexibility gives researchers room to innovate instead of falling back on basic templates.
Clumsy workups eat up hours better spent elsewhere. Compared to unprotected amino acids, Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid allows easier handling. Its Boc cap reduces moisture sensitivity—no more panicking over every humidity spike in the lab. Having run a few reverse-phase chromatography columns, I appreciate how compounds of this class travel through setups without smearing or tailing. Purification becomes less of a guessing game. Melting points hover in a range easy to observe, so checking sample integrity stays simple, even without fancy equipment.
It’s tempting to describe this compound as just another intermediate. In practice, the value to researchers goes beyond its role in solid-phase peptide synthesis. Medicinal chemists use derivatives like this in early drug discovery, probing what small changes to side chains do for binding or selectivity. This one’s structure, with both steric and electronic contributions from its (R)-beta-amino acid backbone and brominated ring, offers a testing ground for structure–activity relationship (SAR) studies. I’ve seen teams move on from generic phenylalanine analogues to brominated aromatics like this, only to spot unexpected activity—sometimes better permeability, sometimes unique receptor affinity. It’s these moments that move projects from obituary piles to the next funding round.
Laboratories pushing the envelope with non-proteinogenic amino acids find themselves returning again and again to bromine-bearing candidates. Instead of sticking to the twenty proteinogenic residues, building in these variants changes peptide folding, stability, and even resistance to proteolytic breakdown. With Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid, a single substitution can transform the biological half-life of a peptide-based drug. My experience monitoring stability by HPLC traces teaches that even modest tweaks, like swapping an unsubstituted phenyl for a 2-bromo version, show up in the results. Longer circulation times open up new therapeutic windows—either for delivery through oral routes or in sustained-release formulations.
Plenty of amino acid derivatives crowd the market. What sets this one apart isn’t just the sum of its functional groups, but the location and handedness of each. Compounds lacking the (R)-configuration often serve other research purposes, but for projects targeting interaction with enzymes or specific transporters, this configurational lock pays dividends. Most competitors offer para- or meta-substituted brominated phenyl groups, changes that influence both reactivity and ultimate bioactivity. A 2-bromo substitution accesses a different catalogue of downstream reactions and structure-based effects. These subtle differences often make or break a campaign searching for novel ligands, probes, or backbone-modified peptides.
My years in the lab have taught me that what looks fine on paper often falls short under a microscope. Purity speaks for itself. Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid from trusted suppliers hits the required bar for low metal residues, limited side-product contamination, and reliable stereochemistry. These factors directly influence reproducibility. Low-level contamination sneaks through if overlooked, wrecking precious late-stage experiments. Researchers need confidence that supply sources maintain careful analytic profiles, including NMR and chiral HPLC traces. Without this diligence in upstream manufacturing, all the downstream experiments end up suspect.
Handling any brominated aromatic calls for awareness, both from an environmental and safety point of view. Experience teaches that a neat synthesis route using greener solvents makes much more difference than any flashy branding. Disposal procedures and storage conditions matter—for brominated intermediates in particular, keeping everything dry and out of strong sunlight helps extend shelf life and avoid dangerous byproducts. Suppliers publishing safety data sheets and providing transparent guidance help researchers handle this compound without stumbling into avoidable accidents. Real trust comes from open sharing of all hazard information, not just a sticker on a bottle.
Getting ahold of rarer amino acid derivatives still challenges research teams far from major distribution networks. Delays jeopardize project milestones and inflate budgets. In my experience, global supply chains improved over the last decade, but shortages or lengthy lead times sometimes return, especially for chiral and functionalized building blocks like Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid. One way to address this: forming purchasing partnerships across labs or working through academic consortia. Bulk orders spread out costs and improve negotiating power with specialty suppliers. Direct communication with manufacturers, especially to set up recurring ordering agreements, reduces the likelihood of running dry an hour before a grant deadline.
A lot of synthetic creativity depends on whether building blocks like this exist at all. In medicinal chemistry, adding a bit of bulk or a halogen in exactly the right orientation creates not just more complicated molecules, but more adaptable ones. Applications spread from drug candidate discovery to enzymology, materials, and even imaging, when these side chains become handles for tagging or conjugation. Some of the most unexpected advances happen when researchers use amino acids bearing strategic modifications—like Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid—instead of falling back on boring, overused standards. Peptide libraries look more interesting, protein mimetics perform better, and patent claims get a little more robust.
There’s a divide between theory and practical utility. Years of running peptide couplings, deprotection cycles, and oxidations taught me one thing: the less time spent troubleshooting, the faster the progress. Choosing a well-characterized compound with known responses under acidic or basic conditions shortcuts the trial-and-error that wastes precious reagent and time. Boc-protected, brominated derivatives like this one survive steps that would damage unprotected or less robust analogues. Relying on a stable, versatile building block streamlines innovation from day one.
Chemistry now faces increasing pressure to do better by the environment and by society. I’ve watched labs move away from hazardous synthetic protocols for specialty amino acids, opting instead for greener routes that minimize waste and use less energy. Products like Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid benefit from such innovations. Suppliers who disclose eco-friendly synthesis routes—often making use of phase-transfer catalysis or solvent minimization—make a difference in more ways than one. Creating a feedback loop between researchers and suppliers, with honest reporting about both environmental impact and reliability, lays the groundwork for more responsible chemistry.
The horizon never stops moving. Pharmaceutical, biotech, and academic labs need more than off-the-shelf solutions—they require compounds with an eye toward unexplored functionality and upcoming regulatory demands. Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid, because of its flexibility and compatibility with modern coupling and derivatization methods, figures prominently in many of these future-proofed approaches. Teams using this as a scaffold find themselves uncovering new routes to macrocycles, peptidomimetics, and targeted covalent inhibitors. As legal and safety hurdles evolve, using established, well-defined starting materials insulates projects from unnecessary risk. Reliable documentation, shared supplier histories, and broad-spectrum application notes become integral to success.
Logistical roadblocks stall groundbreaking results. Through networking and establishing transparent purchasing channels, the scientific community softens the blow from intermittent shortages. Better digital cataloguing and peer-shared evaluations of supplier trustworthiness close knowledge gaps, helping more teams gain access to specialized compounds like this. Open access to analytic data and handling advice, going beyond just paperwork, strengthens outcomes across disciplines.
Nothing matters more to experimentalists than knowing the materials at hand deliver as promised. The journey from ordering a substance to turning it into a key intermediate or final product depends on rich, shared community experiences. Through publishing both syntheses and cautionary tales, the field creates a compendium of knowledge, helping all users approach Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid with both clarity and creative purpose. Scientists choose this particular amino acid not from habit but because it delivers value—creating new tools for healthcare, advanced materials, and analytical applications.
In the high-pressure, results-driven context of research labs, every choice—down to the structure of a single amino acid—can tilt the balance between progress and dead-ends. Boc-(R)-3-Amino-4-(2-Bromophenyl)-Butyric Acid provides a remarkable blend of reactivity, protection, and adaptability. Years of trial, error, and incremental progress demonstrate that fine-tuning at the molecular level often sets projects apart. Whether driving new drug leads, building peptide-based sensors, or venturing into advanced synthesis, tools like this amplify possibilities. Researchers keep it close, not just because of what it is, but because of what it lets them accomplish.